基于HIS灯盏细辛注射液真实世界临床用药特点分析
投稿时间:2012-07-15    责任编辑:  点此下载全文
引用本文:杨薇,程豪,谢雁鸣,杨虎,庄严.基于HIS灯盏细辛注射液真实世界临床用药特点分析[J].中国中药杂志,2012,37(18):2718.
DOI:10.4268/cjcmm20121812
摘要点击次数: 1253
全文下载次数: 92
              
作者中文名作者英文名单位中文名单位英文名E-Mail
杨薇 YANG Wei 中国中医科学院 中医临床基础医学研究所, 北京 100700 Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China  
程豪 CHENG Hao 中国人民大学 统计学院, 北京 100872 Renmin University of China, Beijing 100872, China  
谢雁鸣 XIE Yan-ming 中国中医科学院 中医临床基础医学研究所, 北京 100700 Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China zhinanb2012@ yahoo.com.cn 
杨虎 YANG Hu 中国人民大学 统计学院, 北京 100872 Renmin University of China, Beijing 100872, China  
庄严 ZHUANG Yan 解放军海军总医院, 北京 100048 The PLA Navy General Hospital, Beijing 100048, China  
基金项目:国家"重大新药创制"科技重大专项(2009ZX09502-030)"中药上市后评价关键技术研究"
中文摘要:目的: 了解灯盏细辛注射液的临床应用情况,为规范临床合理用药及前瞻性研究提供思路与指导。 方法: 选取全国20家三甲综合医院使用灯盏细辛注射液的住院患者信息,运用基本数据描述方法及关联规则进行分析。 结果: 在21 498例患者中,用药患者多为45岁以上老年人;主要用于脑梗死(中医诊断为中风)、冠心病、高血压病、糖尿病的治疗;用法以静脉注射为主,单次用药剂量多集中在30~40 mL;用药疗程多为14 d左右。 结论: 灯盏细辛注射液临床使用基本符合药品说明书;患者多为老年患者,且多合并有糖尿病和高血压病。
中文关键词:灯盏细辛注射液  真实世界  医院信息系统  临床用药特点  描述分析  实效研究
 
Dengzhanxixin injection using character analysis in clinical based on real world HIS database
Abstract:Objective: To know the truth how does Dengzhanxixin injection be used in clinical practice, and to regulate clinical use, and to direct the prospective study design. Method: Twenty comprehensive hospital information system (HIS) data are collected. Cleaning up the database, then analysis the patients' information which the patients have used Dengzhanxixin injection. Using the basic description method and association rules to analysis the data. Result: By analysis the Dengzhanxixin data come from HIS database we found that the most patient's age are elder than 45, it was used to treat ischemic stroke, coronary heart disease, diabetes and hypertension. It is always used in the form of intravenous injection, and are always used in 30-40 mL dosage in clinical practice,and it is always used for 14 days for one time. Conclusion: The patients are usually used in old people. And the injection's using in clinical are mostly complied with the instructions. The patients who had been used Dengzhanxixin injection usually have diabetes and hypertension.
keywords:Dengzhanxixin injection  real world  hospital information system  drug using character  descriptive analysis  outcomes research
查看全文   下载PDF阅读器
相关阅读
评论
zuo-jiat you-jiat